Bandingkan Harga & Kinerja Ramayana Lestari Sentosa Tbk. (RALS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Ramayana Lestari Sentosa Tbk. dan Organon Pharma Indonesia Tbk.: Ramayana Lestari Sentosa Tbk. diperdagangkan di Rp390 (kapitalisasi pasar 2,77 T, volume 24 jam 2,68 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ramayana Lestari Sentosa Tbk. jauh lebih besar — sekitar 26,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RALS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,77 T | 104,4 M |
Volume | 2,68 jt | — |
Lot | 26,85 rb | — |
Perputaran | 1,05 M | — |
Harga Rata-rata | 389,41 | — |
Nilai Transaksi | 1,05 M | — |
Harga Ekuilibrium Indikatif | 390 | — |
Volume Ekuilibrium Indikatif | 13 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ramayana Lestari Sentosa Tbk.
PT Ramayana Lestari Sentosa (the Company) was established on December 14, 1983. The Company’s Articles of Association has been amended several times, the latest amended concerning changes in the Company’s authorized capital stock.As december 31, 1999, the Company operates a total of 57 department stores known as Ramayana, Robinson, Bazaaria and 7 department stores known as Cahaya and Jayasera, located in Jakarta, Tangerang, Bekasi, Bogor, Depok, Sukabumi, Bandung, Cimahi, Cirebon, Cilegon, Semarang, Yogyakarta, Surabaya, Gresik, Sidoarjo, Malang, Bali, Lampung and Batam. As September 2001, The Company operates a total of 77 department stores and until the end of 2001 the company plans to open 5 department stores more.The Company started its commercials operations in 1983.
Selengkapnya di halaman RALS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
